Kerala Ayurveda reports revenue growth but losses widen for FY26
Standalone revenue climbed 17.6% to ₹85.48 crore, yet net losses deepened to ₹14.74 crore as the company struggles to turn a profit.
— 2 earlier stories on Kerala Ayurveda Ltd. →What's new
- Standalone revenue rose 17.6% to ₹85.48 crore; consolidated revenue grew 9% to ₹131.15 crore.
- Net losses widened to ₹14.74 crore (standalone) and ₹20.65 crore (consolidated).
- Auditors flagged significant outstanding trade receivables from subsidiaries without provisions.
Why this matters
Revenue growth is failing to translate into profitability, with losses expanding on both a standalone and consolidated basis. The auditor's note on unprovided receivables from subsidiaries raises questions about the quality of the company's balance sheet.
What we're watching
- Management's plan to address the widening net losses.
- Any movement on the outstanding receivables from subsidiaries.
- Whether the company can achieve operational break-even in FY27.
The full read
Kerala Ayurveda posted revenue growth for the year ended March 31, 2026, but the company's financial health remains strained. Standalone revenue grew 17.6% to ₹85.48 crore, while consolidated revenue rose 9% to ₹131.15 crore. Despite these gains, net losses deepened. The standalone net loss widened to ₹14.74 crore from ₹13.78 crore in the prior year, and the consolidated net loss reached ₹20.65 crore. The audit report contains an emphasis of matter regarding significant trade receivables from subsidiaries that lack provisions. This points to a persistent struggle to convert revenue into profit while managing inter-company balances. These results are a routine annual disclosure. The combination of widening losses and unprovided subsidiary receivables leaves little room for optimism.
Questions answered
- How did Kerala Ayurveda perform in FY26?
- The company saw top-line growth, with standalone revenue rising 17.6% to ₹85.48 crore and consolidated revenue increasing 9% to ₹131.15 crore. Bottom-line performance deteriorated, with standalone losses widening to ₹14.74 crore and consolidated losses reaching ₹20.65 crore.
- What concern did the auditors raise?
- The audit report includes an emphasis of matter regarding significant trade receivables owed by subsidiaries. These amounts remain outstanding without any provisions made against them.
- Is this a new development for the company?
- No. The results continue a trend of operating losses, and the filing represents a routine annual financial disclosure.
Story so far
All notes on KERALAYUR →- 25 May 2026 · 7:46 PM IST Kerala Ayurveda reports revenue growth but losses widen for FY26
- today Kerala Ayurveda reports wider losses despite double-digit revenue growth
- today Kerala Ayurveda reports revenue growth alongside widening annual losses